Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Doping - WADA reinstates Madrid anti-doping laboratory

Published 29/04/2017, 04:29
© Reuters. A woman walks into the head offices of WADA in Montreal

MONTREAL (Reuters) - Madrid's Anti-Doping Laboratory was reinstated by the World Anti-Doping Agency (WADA) on Friday, more than a year after it was suspended.

The suspension, which followed WADA's declaration last March that the Spanish Anti-Doping Agency (AEPSAD) was non-compliant, prohibited the lab from carrying out any WADA-related anti-doping activities.

AEPSAD, which had missed a deadline for required changes to its drug-testing procedures, was removed from the non-compliant list early last month and an inspection of the Madrid lab followed on March 23-24.

"We would like to thank the laboratory for their continued cooperation throughout this process," WADA Director General Olivier Niggli said in a statement.

"Given the specific circumstances of their suspension, WADA is confident that the laboratory will continue to operate to the high standards required."

The suspensions led to a dramatic drop in testing in the top two Spanish soccer leagues, with no samples at all taken from players in the second division for a year after AEPSAD's suspension.

© Reuters. A woman walks into the head offices of WADA in Montreal

WADA said in February the lack of testing was "alarming" with AEPSAD blaming FIFA and UEFA for not taking over drug testing in football while it was ruled non-compliant.

(Reporting Nick Mulvenney in Sydney; editing by Amlan Chakraborty)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.